Literature DB >> 2770951

Variations in the distribution of methylguanidine with the progression of renal failure after methylguanidine loading.

T Yokozawa1, N Fujitsuka, H Oura.   

Abstract

Methylguanidine (MG) was intraperitoneally administered to both normal rats and those given adenine, and MG levels in the serum, liver, kidney, muscle, brain and urine were compared. The accumulation of MG in the body increased with the progression of renal failure, whereas the rate of urinary excretion of MG in rats given adenine for 30 days was lower than the corresponding values in rats given adenine for 10 and 20 days. The velocity of MG elimination from serum and tissues became lower as the period of adenine administration lengthened. In particular, the rate of MG elimination from muscle was markedly low in comparison with that from the serum, liver, kidney or brain, and a high concentration of MG was still present 24 h after MG loading. In addition, the amount of MG obtained by subtracting the total amounts detected in the serum, liver, kidney, muscle, brain and urine from the dose decreased gradually as the period of adenine administration lengthened. The MG-scavenging effect is diminished according to the progress of renal failure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2770951     DOI: 10.1159/000185675

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  3 in total

1.  Inhibitory effect of antioxidants on hydroxyl radical generation from methylguanidine: an ESR study.

Authors:  Yasuko Noda; Mitsumasa Mankura
Journal:  Neurochem Res       Date:  2008-08-08       Impact factor: 3.996

2.  Effect of methylguanidine on rat blood pressure: role of endothelial nitric oxide synthase.

Authors:  R Sorrentino; A Pinto
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

3.  Inhibitory effect of fermented papaya preparation on hydroxyl radical generation from methylguanidine.

Authors:  Yasuko Noda; Shinki Murakami; Mitsumasa Mankura; Akitane Mori
Journal:  J Clin Biochem Nutr       Date:  2008-10-31       Impact factor: 3.114

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.